TO THE EDITOR
Sir, benzene is of particular concern because of recent research is indicating that benzene exposure can result in chronic hematologic toxicity. International organizations such as Agency for Toxic Substances and Disease Registry (ATSDR) have documented benzene as a toxic substance and monitoring of exposure for risk population. 1 At present, benzene is a wellknown toxic agent acting as a primary inducer of leukemia. 2 Although the mechanisms underlying benzene-induced toxicity and leukemogenicity are not yet fully understood, they are likely to be complicated by various pathways, including those of metabolism, growth factor regulation, oxidative stress, DNA damage, cell cycle regulation, and programmed cell death. 3 The potential metabolic mechanisms underlying the hemopoietic toxicity of benzene include bioactivation of phenolic metabolites of benzene by myeloperoxidases in the bone marrow and ring opening reactions to generate muconate derivatives. 4 This study is aimed at the knowledge on the correlation between the urine trans, trans-muconic acid (tt-MA), a novel biomarker for accumulated uptake of benzene, 5 and myelopeozidase index (MPXI) in the subjects occupationally exposed to benzene.
A total of 30 Thai male volunteers without a previous history of underlying hematological disorder and occupationally exposed to benzene in their daily work were included in this study. After asking for informed consent, each subject provided a urine sample for tt-MA level determination using the method described by Wiwanitkit et al. 6 In addition, an EDTA blood sample was collected for MPXI analysis using the automated hematology flow cytometry analyzer, Technicon-Hn3. Data were collected for further statistical analysis using SPSS 7.0 for Windows Program. The Kolmogorov-Smirnov test was used to check for normal distributions of the laboratory results in each parameter, and normal distributions in all parameters were detected.
The averages (mean7s.d.) of urine tt-MA level and MPXI were 0.7271.32 mg/g creatinine and 6.2973.06, respectively. The regression analysis showed no significant correlation between urine tt-MA level and MPXI (r ¼ À0.06, P ¼ 0.75). Although there is a previous report that states the correlation between benzene concentration in the air at work places and the change in the neutrophil enzyme, 7 we can detect no significant correlation between the benzene biomarker tt-MA and MPXI.
Of interest, our study is the first report pointing out the possible correlation between urine tt-MA and MPXI. Based on these hematologic data, we proposed that the investigations of the sole urine biomarker for benzene exposure are not sufficient in the detection of putative leukemogesis in the exposed population. Combinations between biomaker and hematological tests are recommended. Further studies with a larger sample size focusing on the details of pathogenesis of red blood cell disorders are also called for.
